MMR deficient EC were significantly more likely to be deemed high-risk for lymph node metastasis by Mayo criteria (74.9% vs 60.6%, p=≤0.001) (Table 1). Here, MRC1 is linked to metastatic malignant neoplasm in the lymph nodes.